Indapamide and Paraneoplastic syndrome - a phase IV clinical study of FDA data

Summary:

Paraneoplastic syndrome is reported as a side effect among people who take Indapamide (indapamide), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Omeprazole, and have Cardiac failure.

The phase IV clinical study analyzes which people have Paraneoplastic syndrome when taking Indapamide. It is created by eHealthMe based on reports of 21,640 people who have side effects when taking Indapamide from the FDA, and is updated regularly.

What is Indapamide?

Indapamide has active ingredients of indapamide. It is often used in high blood pressure. eHealthMe is studying from 22,153 Indapamide users. Check the latest studies of Indapamide.

What is Paraneoplastic syndrome?

Paraneoplastic syndrome (symptom that is the consequence of the presence of cancer in the body) is found to be associated with 96 drugs and 307 conditions by eHealthMe. Check the latest studies of Paraneoplastic syndrome.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

21,640 people reported to have side effects when taking Indapamide.
Among them, 12 people (0.06%) have Paraneoplastic syndrome.

Could Indapamide cause Paraneoplastic syndrome?

Among these 12 people:

How long have people been on Indapamide when they have Paraneoplastic syndrome? *

What is the gender of people who have Paraneoplastic syndrome when taking Indapamide? *

female: 16.67 %
male: 83.33 %

What is the age of people who have Paraneoplastic syndrome when taking Indapamide? *

What are other drugs people take besides Indapamide? *

What are other side effects people have besides Paraneoplastic syndrome? *

Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 10 people, 83.33%
Lung Cancer - Non-Small Cell (lung cancer): 9 people, 75.00%
Pulmonary Embolism (blockage of the main artery of the lung): 9 people, 75.00%
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung): 9 people, 75.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 9 people, 75.00%
Constipation: 1 person, 8.33%
Hypochloraemia (electrolyte disturbance in which there is an abnormally low level of the chloride ion in the blood): 1 person, 8.33%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 8.33%
Fibula Fracture: 1 person, 8.33%
Exercise Tolerance Decreased: 1 person, 8.33%

What are the existing conditions these people have? *

Iron Deficiency Anaemia: 9 people, 75.00%
Cardiac Failure: 9 people, 75.00%
Atherosclerosis (disorder of the arteries): 6 people, 50.00%
Bradycardia (abnormally slow heart action): 5 people, 41.67%
Swelling Face: 1 person, 8.33%
Parkinson's Disease: 1 person, 8.33%
Pain: 1 person, 8.33%
Immune System Disorder: 1 person, 8.33%
High Blood Cholesterol: 1 person, 8.33%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Indapamide and have Paraneoplastic syndrome?

- Check whether Paraneoplastic syndrome is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Indapamide:

Indapamide (22,153 reports)

Browse all side effects of Indapamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Paraneoplastic syndrome:

Paraneoplastic syndrome (96 drugs)

Browse all the conditions that are associated with Paraneoplastic syndrome:

Paraneoplastic syndrome (307 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on indapamide (the active ingredients of Indapamide) and Indapamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.